Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives.
respiratory infection, pneumonia, ARDS, viral infection, cytokine biology
Marta Monguió-Tortajada, Antoni Bayes-Genis, Antoni Rosell, Santiago Roura